Our Pricing

Mounjaro Dursley: Expert Weight Loss Treatment for Gloucestershire Residents

Published: 4 October 2026

Residents searching for Mounjaro Dursley can now access this clinically proven tirzepatide weight loss injection through Cured Pharmacy's fully regulated UK online service. Our GPhC-registered pharmacy (9012511) connects Dursley patients with UK prescribers for fast, discreet assessment and home delivery across Gloucestershire. Clinical trials demonstrate that Mounjaro users achieved average weight reductions of 15-22.5% over 72 weeks, making it one of the most effective pharmaceutical weight loss interventions currently licensed in the UK [1].

How Mounjaro Dursley Residents Access Treatment Online

Accessing Mounjaro Dursley through Cured Pharmacy eliminates the need for in-person GP appointments or travel to physical pharmacies. Our streamlined process begins with a confidential online consultation that takes under three minutes to complete, during which you provide essential medical history including current medications, pre-existing conditions, and weight management goals [2].

Once submitted, your assessment is reviewed by a UK-registered prescriber within 24 hours on working days. If clinically appropriate, your Mounjaro prescription is issued electronically and forwarded to our dispensing team. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure safety and compliance with MHRA regulations. Dursley residents typically receive their medication within 2-3 working days via discreet, tracked courier service.

All Mounjaro prescriptions are subject to clinical approval and require ongoing monitoring. Our prescribers assess your BMI, weight loss history, contraindications such as personal or family history of medullary thyroid carcinoma, and current metabolic health markers before authorising treatment.

Mounjaro Dursley Pricing and Discount Codes

Cured Pharmacy offers transparent Mounjaro Dursley pricing from £124.99 per four-week supply, with no hidden consultation fees or subscription traps. New patients qualify for £20 off their first order using code Weightlossnew, reducing the initial cost to £124.99 and making tirzepatide treatment more accessible to Gloucestershire residents.

Our pricing structure remains consistent regardless of your location in Dursley, Cam, Uley, or surrounding villages. Unlike some providers who increase costs after initial months, Cured Pharmacy guarantees the lowest UK prices on genuine, MHRA-licensed Mounjaro throughout your treatment journey. All prices are displayed upfront before you complete your medical assessment.

Mounjaro Dosage Costs for Dursley Patients

Mounjaro treatment follows a structured dose escalation schedule, beginning at 2.5mg weekly for four weeks, then increasing to 5mg, 7.5mg, 10mg, 12.5mg, and finally the maintenance dose of 15mg. Each dose tier is priced at £124.99 per four-week supply at Cured Pharmacy, ensuring cost predictability as you progress through your weight loss programme [3].

Dursley residents should budget for approximately six months of treatment to reach the maintenance dose, though many patients experience significant weight reduction during the lower-dose phases. Clinical guidance recommends remaining on each dose for at least four weeks to allow your body to adapt and minimise gastrointestinal side effects.

Clinical Evidence Supporting Mounjaro Dursley Weight Loss Results

The SURPASS clinical trial programme provides robust evidence for Mounjaro's efficacy in weight management. In the SURPASS-1 trial, participants receiving 15mg tirzepatide weekly lost an average of 22.5% body weight over 72 weeks, compared to 2.4% in the placebo group [1]. These results represent some of the most substantial pharmaceutical weight reductions documented in peer-reviewed obesity research.

For Mounjaro Dursley patients specifically, these trial outcomes translate to realistic expectations: a person weighing 100kg at baseline might expect to lose 15-22.5kg over 18 months when combining tirzepatide injections with lifestyle modifications. The dual GIP/GLP-1 receptor agonist mechanism suppresses appetite, slows gastric emptying, and improves insulin sensitivity simultaneously [4].

Importantly, SURPASS trials also demonstrated improvements in cardiovascular risk markers including blood pressure, triglycerides, and HbA1c levels in participants with type 2 diabetes. Dursley residents with obesity-related comorbidities may experience additional metabolic benefits beyond weight reduction, though individual results vary and require ongoing medical supervision.

Mounjaro Dursley Delivery and Prescription Process

Once your Mounjaro Dursley prescription is approved, our pharmacy dispenses genuine Eli Lilly KwikPens sourced directly from UK-licensed wholesalers. Each package is shipped in plain, unmarked packaging to protect your privacy, with no external indication of pharmaceutical contents. Delivery to Dursley postcodes (GL11) typically occurs within 2-3 working days via Royal Mail Tracked 24 or DPD courier services.

Your first Mounjaro shipment includes comprehensive patient information leaflets detailing injection technique, storage requirements (refrigerate at 2-8°C), and side effect management. Cured Pharmacy's clinical team remains available via phone (+44 116 4646009) throughout your treatment for any questions regarding administration, dose escalation timing, or adverse reactions.

Repeat Mounjaro Prescriptions for Dursley Residents

Continuing Mounjaro Dursley patients can request repeat prescriptions through their online account dashboard approximately one week before their current supply depletes. Our prescribers review your progress notes, weight loss trajectory, and any reported side effects before approving continuation. This ongoing monitoring ensures treatment remains clinically appropriate and safe as you advance through dose escalations.

Patients who experience plateaus or inadequate weight loss may require dose adjustments or complementary interventions. Our prescribers follow NICE guidelines recommending discontinuation if less than 5% weight loss is achieved after 12 weeks at the maximum tolerated dose, ensuring cost-effective, evidence-based care for all Dursley residents.

Mounjaro Dursley Side Effects and Safety Monitoring

Common Mounjaro side effects reported in clinical trials include nausea (affecting up to 25% of users), diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during the initial dose escalation phases [1]. Dursley residents starting tirzepatide should anticipate mild-to-moderate gastrointestinal symptoms that typically diminish after 4-8 weeks as the body adapts to the medication.

Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (especially when combined with insulin or sulfonylureas). Our prescribers conduct thorough medical history reviews to identify Dursley patients at elevated risk, excluding those with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [5].

If you experience persistent vomiting, severe abdominal pain radiating to the back, or signs of allergic reaction while using Mounjaro Dursley treatment, discontinue injections immediately and contact NHS 111 or your GP. Cured Pharmacy's superintendent pharmacist can provide guidance on managing mild side effects and determining whether dose reduction or treatment cessation is warranted.

Mounjaro Dursley Alternatives and Treatment Comparisons

While Mounjaro Dursley residents often achieve superior weight loss outcomes compared to older GLP-1 agonists, alternative treatments may suit certain clinical profiles or budgets. Wegovy (semaglutide) injections, available from £124.99 at Cured Pharmacy, demonstrated 14.9% average weight reduction in STEP trials—slightly less than tirzepatide but still highly effective [6].

For patients preferring oral medications, Wegovy tablets and Foundayo pills offer needle-free alternatives, though absorption rates and efficacy differ from injectable formulations. Dursley residents with BMI 28-30 and minimal comorbidities might consider Orlistat (£124.99) as a first-line option before escalating to GLP-1 receptor agonists, following the stepped approach recommended by NICE guidelines.

Our prescribers assess your individual circumstances—including previous weight loss attempts, contraindications, injection anxiety, and financial considerations—to recommend the most appropriate treatment. Mounjaro Dursley patients benefit from personalised care that balances clinical evidence with practical feasibility and patient preference.

Switching from Other Weight Loss Treatments to Mounjaro Dursley

Dursley residents currently using Saxenda, Wegovy, or Orlistat can transition to Mounjaro under prescriber supervision. When switching from another GLP-1 agonist, a washout period is typically unnecessary, though your prescriber will determine the appropriate Mounjaro starting dose based on your current regimen and tolerance history [7].

Patients switching from Orlistat to Mounjaro Dursley should expect a different side effect profile—transitioning from fat malabsorption symptoms to appetite suppression and nausea. Our clinical team provides detailed transition guidance to optimise safety and minimise treatment interruption during the changeover period.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 4 October 2026]
2. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [ID6204]. NICE guideline development. [accessed 4 October 2026]
3. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Datapharm Ltd. [accessed 4 October 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 4 October 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Tirzepatide (Mounjaro): Risk of thyroid C-cell tumours - advice for healthcare professionals. Drug Safety Update, 16(8). [accessed 4 October 2026]
6. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 4 October 2026]
7. Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., ... & Bray, R. (2023). American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan. Endocrine Practice, 29(5), 305-345. [accessed 4 October 2026]
8. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & STEP 5 Study Group. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 4 October 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 4 October 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 4 October 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 4 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.